In DPP4-deficient rats with streptozotocin-induced diabetes, the onset of hyperglycemia was delayed and circulating insulin levels were higher than in wild types [42,86]; similarly, treatment with DPP4-Is improved glucose tolerance and insulin sensitivity in diabetic rats, despite an overall increased nutrient intake and weight gain, with ameliorated β cell morphology and functionality [86]. Here, DPP4 is linked to Hyperglycemia.